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GermanyABSTRACT RNA interference (RNAi) offers a powerful tool to specifically direct the degradation of complementary RNAs, and
thus has great therapeutic potential for targeting diseases. Despite the reported preferences of RNAi, there is still a need for new
techniques that will allow for a detailed mechanistic characterization of RNA-induced silencing complex (RISC) assembly and
activity to further improve the biocompatibility of modified siRNAs. In contrast to previous reports, we investigated the effects of
20-O-methyl (20OMe) modifications introduced at specific positions within the siRNA at the early and late stages of RISC
assembly, as well as their influence on target recognition and cleavage directly in living cells. We found that six to 10 20OMe
nucleotides on the 30-end inhibit passenger-strand release as well as target-RNA cleavage without changing the affinity, strand
asymmetry, or target recognition. 20OMemodifications introduced at the 50-end reduced activated RISC stability, whereas incor-
porations at the cleavage site showed only minor effects on passenger-strand release when present on the passenger strand.
Our new fluorescence cross-correlation spectroscopy assays resolve different steps and stages of RISC assembly and target
recognition with heretofore unresolved detail in living cells, which is needed to develop therapeutic siRNAs with optimized in vivo
properties.INTRODUCTIONRNA interference (RNAi) is an evolutionary conserved gene-
silencing mechanism that uses short, double-stranded RNAs
(dsRNAs) to identify complementary target RNAs for
sequence-specific degradation (1). The RNAi mechanism
requires a ribonucleoprotein complex known as the RNA-
induced silencing complex (RISC), which is composed of
an Argonaute (Ago) protein associated with a short, single-
stranded RNA of 19–30 nucleotides (nt). These short guide
RNAs originate from endogenous or exogenous dsRNA
substrates of various secondary structures (2–5). To function
as guiding cofactors, the short dsRNAs are bound by the
RISC loading complex (RLC), which consists of Dicer,
TRBP, and a member of the Argonaute protein family
(4,6,7). The selection of the latter guide RNA is governed
by the thermodynamic stability of the duplex termini (8).
For target recognition, RISC is guided by single-stranded
RNA on the basis of sequence complementarity. In the
current two-state model, not all positions of the guide RNA
participate equally in target recognition (9,10). Therefore,
nucleotides 2–8 of the guide strand (termed the seed
sequence) mediate the primary interaction with the target
RNA.Once the seed sequence primes to the target, the duplex
formation propagates toward the 30-end, leading to a con-
formational change in Argonaute (11–13). Depending on
the extent of complementarity in conjunction with the asso-
ciated Argonaute family member, RISC can trigger geneSubmitted March 9, 2011, and accepted for publication May 5, 2011.
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0006-3495/11/06/2981/10 $2.00expression by endonucleolytic cleavage, translational
repression, deadenylation, decapping, and/or translocation
into P-bodies (reviewed in Chekulaeva and Filipowicz (14)).
One class of small, silencing RNAs is composed of short
interfering RNAs (siRNAs), which consist of a dsRNA stem
of ~19 nt containing a 50-phosphate and 2 nt overhangs at
both 30-ends (3,5). The identification of siRNAs resulted
in the development of chemically synthesized siRNAs to
specifically trigger the degradation of targeted mRNA tran-
scripts in mammalian cells (15). Recent advances in chem-
istry and oligonucleotide synthesis lead to the development
of therapeutic siRNAs with improved pharmacokinetic and
pharmacodynamic properties (16–19). Therefore, various
modifications, such as the phosphorothioate (PTO) back-
bone modification and 20-O-methyl (20-OMe) and 20-fluoro
(20F) sugar modification, have been comprehensively eval-
uated for their use in siRNA-based medical therapies
(18–24). The PTO modification is compatible with siRNA
function, leads to an increased half-life in serum, and facil-
itates cellular uptake; however, it also lowers thermal duplex
stability, can display cytotoxic effects, and promotes non-
specific protein binding. This is illustrated by the strong
affinity to polyanion-binding proteins, which results in
accumulation in the nucleus and P-bodies and can poten-
tially cause unwanted side effects, thereby limiting its use
in siRNA-mediated silencing (20–23,25).
The incorporation of the 20F modification on pyrimidines
also stabilizes the siRNA duplex against nucleases without
affecting the silencing activity, but also results in a strong
localization in the nucleus (22–24).doi: 10.1016/j.bpj.2011.05.005
2982 Ohrt et al.The nontoxic 20-OMe RNA modification is a naturally
occurring RNA alteration that is found inmammalian tRNAs
and rRNAs and does not alter siRNA subcellular localization
(23). Furthermore, the substitution of a single 20-OMe modi-
fication at position 2 of the guide strand reduces silencing of
most off-target transcripts with complementarity to the seed
region without affecting the silencing efficacy of the target
mRNA (26). Increased 20-OMe modification rates stabilize
the duplex against nucleases, but can reduce or completely
abolish silencing activity of siRNAs (22,23,27). 20-OMe
modifications on nucleotides 18–21 resulted in increased
silencing rates after 48 h (23). Although the 20-OMe modifi-
cation can result in inactive duplexes or silencing of inhibited
duplexes, it provides a natural and powerful tool that can be
used to specifically increase the lifetime, specificity, and
potency of siRNAs needed for RNAi-based pharmaceuticals
(20,22,27). So far, investigators have studied the effects of
20-OMe modification on siRNA-mediated silencing by clas-
sical silencing readouts, either by targeting an endogenous
gene analyzed by Western blot or quantitative reverse tran-
scription-polymerase chain reaction, or by standard reporter
assays such as mRFP/EGFP expression or the dual luciferase
assay (20–24,27). Still, little is known about the mechanism
of silencing inhibition by 20-OMe nucleotides, which can
affect factors such as the affinity to RISC, strand separation,
cleavage activity, and the stability of the incorporated guide
strand. In addition, the ability to directly analyze the RNAi
mechanism in living cells in real time at the early phase of
RISC activation (1–6 h) (28) could result in a more detailed
characterization of modified siRNAs, which is needed to
further improve RNAi-based pharmaceuticals.
We recently established fluorescence cross-correlation
spectroscopy (FCCS) assays that allowed us to investigate
the origination of nuclear RISC in a living cell in real time
with single-molecule sensitivity (28). The FCCS method
has a high sensitivity and makes it possible to directly access
strand separation, guide-strand incorporation (including the
duration of incorporation), andRISC-target-RNA interaction
independently of reporter systems, translational regulation,
and knock-down of an mRNA or protein, which require
longer incubation times and cannot locate the individual
step of silencing inhibition.
Here, we report on the positional effects of 20-OMe modi-
fications in siRNAs on the 50-end, 30-end, and at the cleavage
site of either the guide or passenger strand or in combination.
By applying FCCS, we were able to perform this character-
ization in real time and in different cellular compartments.
We show for the first time, to our knowledge, that stretches
of modifications longer than 4 nt inhibit strand separation
and increase the lifetime of the RISC-target interaction by
inhibiting the cleavage activity of Ago2, and that modifica-
tion of the 50-end results in the destabilization of the
Ago2–guide-strand interaction. Internal 20-OMe modifica-
tions display only marginally inhibitory effects on strand
separation and cleavage activity.Biophysical Journal 100(12) 2981–2990MATERIALS AND METHODS
Cell culture
ER293 cells stably transfected with the pERV3 vector (Stratagene, Santa
Clara, CA)were cultured at 37C inDMEM (high glucose; Sigma. St. Louis,
MO) with 10% fetal calf serum (FCS; PAA Laboratories GmbH, Pasching,
Austria), 2 mM glutamine (Gibco, Carlsbad, Ca), and 0.3 mg/ml G418
(50 mg/ml; Gibco).
The cell line 10G, which stably expresses EGFP-Ago2 (introduced by
Ohrt et al. (28)), was cultured at 37C in Dulbecco’s modified Eagle’s
medium (high glucose; Sigma) with 10% FCS, 2 mM glutamine, 0.3 mg/ml
G418, and 0.4 mg/ml Hygromycin B. All cells were regularly passaged at
subconfluency and plated at a density of 1–5  104 cells/ml.Microinjection
For microinjection, 5–10  104 10G cells were transferred onto MatTek
chambers coated with Fibronectin (25 mg/ml in phosphate-buffered saline
including CaCl2 and MgCl2; Roche, Basel, Switzerland) 24 h before micro-
injection. The micropipette (Femtotip 2; Eppendorf, Hamburg, Germany)
was loaded with 1.5–4 mM of labeled siRNAs in 110 mM K-gluconate,
18 mM NaCl, 10 mM HEPES pH 7.4, and 0.6 mM MgSO4. The microma-
nipulator consisted of a FemtoJet and InjectMan NI2 mounted directly on
a microscope. The working pressure for injection was 20–40 hPa for
0.1 s and a holding pressure of 15 hPa.FCCS setup
FCCSand laser scanningmicroscopywere carried out on a commercial system
consisting of an LSM510 and a ConfoCor3 (Zeiss, Oberkochen, Germany).
The 488 nm line of an Ar-Ion laser and the 633 nm line of a HeNe laser
were attenuated by an acousto-optical tunable filter to 3.5 kW/cm2 and
1.05 kW/cm2, and directed via a 488/633 dichroic mirror onto the back aper-
ture of a Zeiss C-Apochromat 40, N.A. ¼ 1.2, water immersion objective.
Fluorescence emission light was collected by the same objective and split
into two spectral channels by a second dichroic (LP635). To remove any
residual laser light, a 505–610nmbandpass or 655nm longpass emissionfilter,
respectively, was employed. The fluorescence was recorded by avalanche
photodiodedetectors (APDs) ineachchannel.ForEGFP-Ago2autocorrelation
measurements, a mirror was substituted for the second dichroic and a 505 nm
longpass emission filter was used in a one-channel setup.Out-of-planefluores-
cence was reduced with a 70 mm pinhole. The fluorescence signals were
software-correlated and evaluated with MATLAB (The MathWorks, Natick,
MA) via a weighted Marquardt nonlinear least-square fitting routine.
Laser scanning microscopy was performed with the APDs of the Con-
foCor3 on the same setup. Cell measurements were performed in air-buffer
(150 mM NaCl, 20 mM HEPES pH 7.4, 15 mM glucose, 150 mg/ml bovine
serum albumin, 20 mM Trehalose, 5.4 mM KCl, 0.85 mMMgSO4, 0.6 mM
CaCl2) at room temperature.RESULTS
Establishment of delivery and FCCS compatibility
conditions of modified siRNAs
We investigated 20-OMe, PTO, and 20F RNA modifications
(the most commonly used and characterized RNA modifica-
tions) for their compatibility with our recently published
intracellular FCCS assay (28). Differently modified Cy5-
labeled siRNAs were microinjected into ER293 cells, and
their subcellular localization and diffusion was studied in
living cells. As described previously (23), the PTO and 20F
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FIGURE 1 Illustration of the FCCS assays used in this study. (A) Incor-
poration assay. An intracellular FCCS assay was used to study the incorpo-
ration of the guide strand. The incorporation of the labeled guide strand
Effects of 20-OMe Modified siRNAs 2983modifications alter the subcellular localization of siRNAs
from a predominantly cytoplasmic localization to a preferen-
tially nuclear localization, as illustrated by a strong and
punctuate accumulation of these siRNAs in the nucleus
(see Fig. S1 A, lower panel in the Supporting Material). In
previous experiments, we showed that unmodified siRNAs
were excluded from the nucleus in an Exportin-5 (Exp5)-
dependent process (29). To rule out the possibility that the
predominantly nuclear localization was not due to reduced
binding affinities of the modified duplexes to Exp5, we
developed a two-color fluorescence RNA electrophoretic
mobility shift assay (REMSA). Here, the affinity of modified
siRNA duplexes (Cy5-labeled; red) to Exp5 in the presence
of increasing amounts of unmodified competitor siRNA
(Alexa488-labeled; green) is determined. The advantage of
the two-color REMSA is that the amount of shifted com-
petitor siRNA intensity can be measured and quantified
simultaneously with the fluorescence intensity of the modi-
fied duplexes. We found that modified and unmodified
siRNA duplexes decreased in shifted fluorescence intensity
in almost identical competitor-dependent manner (Fig. S2).
This result indicates that the alteration of the subcellular
localization in the case of 20F- and PTO-modified siRNAs
was not caused by changed affinities to Exp5, and most
probably resulted from the previously reported affinity of
PTO and 20F modifications to polyanion-binding proteins
concentrated in this organelle (25).
Intracellular FCCS analysis of 30–4-nt-long PTO- and
20F-modified siRNAs displayed strong bleaching rates of
up to 70% for the Cy5-labeled siRNAs, especially in the
nucleus, which made it impossible to obtain quantitative
results (Fig. S1 B, lower panel). This strong photobleaching
may arise from the increased dwell times of the siRNAs
in the excitation volume caused by the aforementioned
increased affinity of PTO and 20F modifications to polyan-
ion-binding proteins, which greatly reduces their mobility
(25). In contrast, the 20-OMe-modified siRNAs conserved
the preferentially cytoplasmic localization independently
of the position and quantity of the 20-OMe modifications
(Fig. S1 A, upper panel and Fig. S3) with moderate bleach-
ing rates of 10–20% after 4 min (Fig. S1 B, upper panel).
Therefore, the 20-OMe modification is suitable for a
detailed FCCS analysis of modified siRNAs in living cells
to investigate position- and quantity-dependent effects on
siRNA affinity to RISC, strand separation, asymmetry,
guide-strand incorporation, the stability of the guide RNA-
RISC interaction, target RNA recognition, and cleavage.results in increased cross-correlation amplitudes (red curve), whereas the
incorporation of the nonlabeled passenger strand results in low cross-corre-
lation amplitudes (black curve). (B) Target interaction assay. An intracel-
lular FCCS assay was used to study the interaction of EGFP-RISC with
its fluorescently labeled target RNA. A stable interaction can be observed
for miRNAs that do not display RNA-cleavage activity, resulting in
increased cross-correlation values (red curve), whereas no stable interaction
can be observed for RISC complexes loaded with a guide RNA showing no
sequence similarities or a guide strand leading to RISC-mediated target
RNA cleavage (black curve).FCCS assays for investigating the RNAi pathway
in living cells
To study the incorporation of the guide strand, asymmetry,
and the stability of the RISC-guide RNA complex, we mi-
croinjected Cy5-labeled siRNAs into an EGFP-Ago2 stable
expressing cell line with endogenous expression levels (28)and measured the cross-correlation amplitudes after dif-
ferent incubation times. The incorporation of the labeled
strand resulted in increased cross-correlation amplitudes
(Fig. 1 A, red curve), whereas the incorporation of the non-
labeled strand led to low cross-correlation amplitudes
(Fig. 1 A, black curve).
To investigate the RISC-target interaction, the EGFP-
Ago2 expressing cell line was transfected with nonlabeled
siRNAs and microinjected with a 50-nt-long, Cy5-labeled
target RNA24 h after transfection (Fig. 1B). The stable inter-
action of RISC with the target RNA resulted in increased
cross-correlation amplitudes (Fig. 1 B, red curve), whereas
RISC-mediated cleavage or no interaction led to low cross-
correlation amplitudes (Fig. 1 B, black curve) (28).Increased 20-OMe modifications on the 30-end
inhibit strand separation and target RNA cleavage
To study the incorporation and strand separation of 20-OMe-
modified siRNAs intracellularly, we used siTK3 siRNA,
which targets the mRNA of Renilla luciferase encoded on
the plasmid pRL-TK but does not show any sequence
homology with endogenous mRNA transcripts. We calcu-
lated the 50-end hybridization energy of siTK3 as described
previously (8) to define the guide and passenger strand of
the siTK3 duplex (Fig. 2 A). We used siTK3 siRNA because
it displays a strictly asymmetric incorporation of the guideBiophysical Journal 100(12) 2981–2990
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FIGURE 2 Effects of 30-20-OMe modifications on silencing, guide-strand incorporation, strand separation, and asymmetry. (A) Illustration of the siTK3
siRNA with 20OMe nt positions of the various modified strands. ER293 cells were transfected with the indicated amounts of differently modified siTK3
together with the fixed concentration of the pGL2-Control and pRL-TK reporter plasmids. After 48 h, the ratios of target to control luciferase concentration
were normalized to the NegsiRNA control (black bar). Unmodified siTK3, lined bar; siTK3 304nt, light gray; siTK3 306nt, gray; siTK3 308nt, dark gray;
siTK3 3010nt, open bar. The plotted data were averaged from six independent experiments 5 SD. (B) ER293 cells were transfected with the indicated
amounts of siTK3 modified on the 30-end with either 4 or 8 20-OMe nt as illustrated in the graph. After 48 h, the ratios of target to control luciferase concen-
tration were normalized to the NegsiRNA control. The plotted data were averaged from six independent experiments5 SD. (C and D) Cross-correlation
amplitudes in the cytoplasm (solid bars) and nucleus (open bars) after 3 and 12 h of incubation for the indicated siRNAs. Mean values 5 SE.
2984 Ohrt et al.strand (23) and high levels of Renilla luciferase silencing
(Fig. 2 A).
To investigate the positional effects of 20-OMe modifica-
tions within small RNAs, we generated siRNAs with con-
stantly increasing numbers of 20-OMe modifications on
the 30-end (Fig. 2 A). The introduction of 4 20-OMe-modi-
fied nucleotides at the 30-end resulted in increased silencing
activity compared with unmodified siRNAs as detected in
a dual-luciferase silencing readout. On the other side, the
introduction of 6 20-OMe nt resulted in strongly reduced
silencing activity and was completely abolished with
8 and 10 20-OMe nt on the 30-end (Fig. 2 A). To investigate
whether the inhibition was caused by modification of the
guide or passenger strand, we measured the silencing
activity of only partially modified siRNA duplexes. We de-
tected identical silencing rates for the siRNA duplex modi-
fied on the passenger strand with 8 20-OMe nt compared
with the control, whereas the modification on the guide
strand resulted in an almost complete loss of silencing
activity (Fig. 2 B). In agreement with the results for the
siTK3 duplex, a second siRNA modified on the 30-end
with 8 20-OMe nt targeting Renilla luciferase completely
lost its silencing activity (data not shown).Biophysical Journal 100(12) 2981–2990To further characterize the mechanism of inhibition, we
tested the interaction of the differently modified siRNAs
with Ago2 by FCCS in living cells. To that end, we microin-
jected guide-strand-labeled siTK3 duplexes into EGFP-
Ago2 cells and analyzed the amount of loaded Ago2 by
FCCS after 3 and 12 h (Fig. 2C). We specifically chose these
two time points because the 3 h value represents the early
(still rising RISC-loading level) and 12 h represents the
late RISC-activation phase (already declining RISC-loading
level) (28). Therefore, they are ideally suited to investigate
strand separation and RISC stability, as both time points
display almost identical loading levels in the cytoplasm.
Under our experimental conditions with guide-strand-
labeled siTK3 duplexes, we detected no differences in the
guide-strand affinity to Ago2 between a silencing active
4 nt modified duplex and the silencing impaired duplexes
containing 6–10 20OMe nt. All labeled guide strands were
incorporated equally well with cross-correlation amplitudes
of ~30–35% (Fig. 2 C). This indicates that the silencing
inhibition is not a result of reduced affinities to the RLC
resulting from the 20-OMe modification. Therefore, the
20-OMe modification on the 30-end does not influence the
affinity to the RLC/RISC.
Effects of 20-OMe Modified siRNAs 2985To study the effect of 20-OMe modifications on strand
separation and asymmetry, we microinjected the aforemen-
tioned modified siTK3 duplexes labeled on the passenger
strand and compared the resulting cross-correlation ampli-
tudes with the guide-strand-labeled duplexes (Fig. 2 C).
The silencing active duplex containing 4 20-OMe modifica-
tions on the 30-end displayed almost no interaction of RISC
with the labeled passenger strand. With increasing amounts
of introduced 20-OMe nt, the interaction of the labeled
passenger strand with RISC increased in the cytoplasm as
well as in the nucleus. For the completely inhibited duplexes
containing 8 and 10 20-OMe nt, we obtained almost identical
incorporation levels in the cytoplasm after 3 h compared
with guide-strand-labeled duplexes, whereas after 12 h we
detected a clear reduction of RISC-interacting passenger
strands (Fig. 2 C). Because we detected silencing inhibition
by 20-OMe modifications only on the guide strand (Fig. 2 B),
we microinjected siRNAs that were modified with 8 nt
20-OMe modifications on the guide or passenger strand
only, and investigated passenger-strand release after 3 and
12 h (Fig. 2 D). In agreement with the silencing experi-
ments, we found that strand separation was mainly inhibited
when the guide strand of the duplex was modified, whereas
the modified passenger strand showed only marginal effects
(Fig. 2 D). These results indicate that 20-OMe-modified
duplexes do not interfere with the asymmetry or the binding
affinity to RISC, but clearly inhibit the strand separation
during the activation of RISC. A selection of the measured
cross-correlation curves is shown in Fig. S4 A.
We note that the level of nuclear-loaded RISC constantly
increased with larger amounts of remaining passenger strand
in RISC after 3 h. A similar effect was previously observed
for nuclear RISC targeting 7SK snoRNA inhibited in
target-mediated cleavage by secondary structures in the
target RNA or bulges between the target guide strand at
the cleavage site (28). In addition, it has been shown thatA
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Only siTK3-4nt was able to cleave the target RNA; no cleavage product can be
serves as a fluorescent label for RISC that can interact with the Cy5-labeled targe
cells. Cross-correlation measurements were performed 1, 2, or 3 h after microin
measurements obtained in the cytoplasm and nucleus, respectively. The number
experiments with the siRNAs modified with 4, 6, 8, and 10 20-OMe nt are showhAgo2 containing RISC cleaves the passenger strand during
activation to facilitate strand separation (30). Therefore, we
tested the hAgo2-mediated cleavage activity of RISC loaded
with a guide strand modified with either 4 or 8 20-OMe nt in-
vitro (Fig. 3 A). Consistent with the dual luciferase silencing
assays, only siTK3-4nt was able to specifically cleave the
siTK3 target RNA, whereas siTK3-8nt displayed no detect-
able cleavage activity. Therefore, the 8 20OMe nt on the
30-end clearly inhibited Ago2-mediated cleavage, thereby
interfering with passenger-strand cleavage and release, as
indicated by the increased levels of passenger strand
compared with siTK3-4nt after microinjection (Fig. 2 C).
Of interest, the level of passenger-strand-labeled duplex
bound to RISC strongly decreased after 12 h compared
with 3 h. This indicates that in addition to the cleavage-
mediated passenger-strand release, a bypass mechanism
exists that also results in strand separation and passenger-
strand removal (Fig. 2 C). The possibility that the duplex
was released during the incorporation period can be
excluded because we did not obtain reduced interaction
levels of the guide-labeled duplex. This bypass mechanism
is much slower and time-consuming than the cleavage-medi-
ated mechanism.
In a previous study (28) we showed that it is possible to
investigate RISC-target interactions via FCCS in living cells
by microinjecting a 50-nt-long, single-stranded, and fluores-
cently labeled RNA containing the target sequence for
siTK3, which is stabilized by 7 20-OMe nt on both ends.
FCCS measurements in nontransfected cells and cells trans-
fected with a control siRNA sharing no sequence comple-
mentarity with the target RNA (NegsiRNA) displayed no
interaction between EGFP-Ago2/RISC and the target
RNA after 1–3 h (Fig. 3 B). This demonstrates the absence
of miRNA-binding sites within the target RNA and the spec-
ificity of the RISC-target RNA interaction assay, as the pres-
ence of siRNAs leading to an miRNA-like interaction3h2h1h
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2986 Ohrt et al.results in increased levels of target RNA bound to RISC
(Fig. 3 B). The fraction of bound target RNA by RISC
was strongly decreased in the presence of a perfect matching
guide strand (siTK3-4nt) due to the cleavage of the target
RNA followed by the release of the cleavage products
from RISC (Fig. 3 B). The levels of RISC bound to the target
RNA increased with the amount of incorporated 20-OMe
modifications and correlated with the aforementioned
silencing activities of the siRNAs containing 6–10 nt at
the 30-end (Fig. 3 B). A selection of the measured cross-
correlation curves is shown in Fig. S4 B. To rule out any
concentration-mediated effects or changed EGFP-Ago2
expression levels, the average number of particles obtained
from the autocorrelation curves is shown in the inset of
Fig. 3 B, which clearly demonstrates homogeneous levels
for both species over the time of the experiment. Of interest,
RISC loaded with the modified guide RNAs containing
8–10 20-OMe nt displayed even higher interaction levels
compared with RISC loaded with a bulge-forming guide
strand. These higher amplitudes may result from a stabiliza-
tion effect of the 20-OMe modification on the RISC-target
interaction. This can be caused by the increased affinity
due to the complete hybridization of the guide-target RNAA
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Biophysical Journal 100(12) 2981–2990duplex or by the protection of the guide strand against
nucleases.20-OMe modifications on the 50-end lead to
destabilization of the RISC-guide RNA interaction
After characterizing the effect of 20-OMe modifications on
the 30-end, we wanted to test the influence of two 20-OMe
modified nucleotides on the 50-end of siRNAs. In the
silencing readouts, a strong decrease of silencing activity
was detected when the 20-OMe modifications were present
on the 50-end (Fig. 4 A). To identify whether the inhibition
results from the guide or the passenger strand only, we
also analyzed duplexes with either the guide or the
passenger strand. The duplex with the 50-end guide-strand
modification showed the same silencing inhibition as the
dual-modified siRNA, whereas the modification on the
passenger strand had no impact on the silencing activity
(Fig. 4 A). We then analyzed the affinity of the 50-end
modified siRNAs to RISC by microinjecting the guide-
strand-labeled duplex. We detected the same amount of
guide-strand-loaded RISC compared with the unmodified
duplex after 3 h (Fig. 4 B). From this result we can concludeB
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Effects of 20-OMe Modified siRNAs 2987that the affinity to the RLC/RISC is not affected. However,
after 12 h we detected a strong decrease in guide-strand-
loaded RISC by approximately one-third (34% down to
22%), whereas the levels of unmodified duplexes remained
stable (Fig. 4 B). This result shows that the 50-20OMe modi-
fication destabilizes the interaction of RISC with the modi-
fied guide strand and not with the duplex, as we could not
detect increased levels of passenger-strand–RISC interac-
tion. This destabilization may cause the relatively strong
silencing inhibition measured in the silencing assay
(Fig. 4 A). The asymmetry of the 50-end 20OMe-modified
siRNAs was not affected, as the passenger-strand-labeled
duplex displayed values comparable to those obtained in
the unmodified control duplex (Fig. 4 B).
We microinjected the fluorescently labeled target RNA in
50-20-OMe-transfected 10G cells to elucidate the impact of
the 50-20-OMe modification on target interaction. We clearly
detected increased interaction levels of RISC with its target
RNA compared with the negative control (NegsiRNA) or
a cleavage active siRNA (siTK3-4nt; Fig. 4 C). Although
the levels are marginally lower compared with the siTK3-
bulge positive control, this could result from the destabilized
interaction of the guide strand with RISC. Nevertheless, the
20-OMe modification on the 50-end has an impact on the
stability and cleavage activity of RISC, but does not inter-
fere with the loading machinery and asymmetry of the
duplex.
So far, we were able to detect increased interaction levels
of silencing inhibited RISC loaded with differently modified
guide RNAs on the 30- or 50-end with its target RNA. We
plotted the fraction of target RNA bound RISC versus the
silencing activity for 1, 2, and 3 h to see whether a correla-
tion exists between silencing activity and target interaction
(Fig. 4 D). Of interest, we detected a linear relationship
between the silencing activity and target RNA bound by
RISC at different time points. By applying this assay,
were able to calculate the cleavage activities of modified
siRNAs by the level of interaction with their target RNA.
However, the reduction of the slope may be due to degrada-
tion of the target RNA with increasing incubation times or
translocation into P-bodies.0
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poration, strand separation, asymmetry, and RISC-target interaction. (A)
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(open bars) after 3 and 12 h of incubation for the indicated siRNAs (mean5
SE). (B) Target interaction levels with EGFP-RISC determined by FCCS
in living cells. Cross-correlation measurements were performed 1, 2, or
3 h after microinjection. Data are represented as the mean5 SE; solid and
open bars indicate measurements obtained in the cytoplasm and nucleus,
respectively.20-OMe modifications on positions 9–11 have only
minor effects on silencing activity and strand
separation
It has been shown in vitro that 20-OMe modifications can
inhibit passenger-strand cleavage and strand separation at
position 9 of the passenger strand (31). We therefore sought
to determine how 20-OMe modifications modulate RISC
activity at the cleavage site in living cells. To that end, we
modified the guide and passenger strand at positions 9–11
starting from each 50-end with 20-OMe (siTK3-Int). In the
dual luciferase silencing assay, we could only detect minor
changes in silencing activity (<8%) for the double andguide-modified duplexes (Fig. S5). Within the accuracy of
our FCCS assay, the internal modification had no effect on
affinity to RISC and asymmetry (Fig. 5 A). However, we
could detect increased interaction levels of labeled passenger
strand (ss-Cy5) with the dual-modified (3nt-Int-as/ss) and
passenger-strand-modified (3nt-Int-ss) duplexes compared
with the siTK3-304nt duplex (4nt-30-as/ss; Fig. 5 A).
In contrast, the guide-strand-modified duplex (3nt-Int-as)
displayed no detectable effect on strand separation, and
showed almost identical interaction levels comparedwith the
passenger-strand-labeled siTK3-304nt duplex (4nt-30-as/ss).
The levels of siTK3-Int guide-strand-loaded RISC bound
to the target RNAwere slightly increased compared with the
siTK3-304nt displaying cleavage activity, and lower in rela-
tion to the bulge-forming guide strand (Fig. 5 B).
Consistent with the moderate effects measured in the
silencing assays, the intracellular FCCS analysis detected
only small inhibitory changes in strand separation and target
interaction. Nevertheless, it also demonstrated the high
sensitivity of our FCCS assays in living cells, as even small
changes in silencing activity of <8% were clearly visible
and allowed for the clear detection of individual inhibited
steps.Biophysical Journal 100(12) 2981–2990
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Up to now, the initial steps of RISC formation (i.e., those
occurring in the first 1–6 h after siRNA delivery (28))
have been mainly inaccessible with conventional assays.
To better understand the inhibitory effect of 20OMe or other
introduced modifications on siRNA-mediated silencing, we
need to develop new intracellular assays that can analyze
RISC formation and target interactions in their initial and
late phase. By using a combination of an EGFP-Ago2
reporter cell line, specific delivery of fluorescent siRNAs
via microinjection, and FCCS, we were able to analyze
differently 20OMe-modified siRNA duplexes with respect
to RISC affinity, strand asymmetry and separation, activated
RISC stability, target interaction, and RISC-mediated target
RNA cleavage in living cells at the early and late phases of
RISC activation.
In contrast to previous reports, we were interested in the
individual mechanistic effects of 20OMe modifications at
different positions within siRNAs on RISC assembly and
activity intracellularly. We were able to show that 20OMe
at different positions within the siRNA leads to several
ways of RISC activity inhibition. We specifically decided
to investigate the 20OMe modification, as PTO and 20F
modifications were incompatible with our intracellular
FCCS assay. This was due to intense photobleaching caused
by the strong nonspecific affinity for cellular proteins and
structures. This is consistent with the changed subcellular
localization of PTO and 20F-modified duplexes reported
previously (23). Therefore, such modified duplexes or
single-stranded PTO or 20F modified RNAs cannot be inves-
tigated by standard FCS/FCCS intracellularly. Furthermore,
20OMe nt are very interesting siRNA modifications because
they can be used to specifically increase the lifetime, spec-
ificity, and potency of siRNAs, as well as inhibit RNA-medi-
ated gene silencing.
In standard dual luciferase assays, we investigated the
effect of increasing amounts of 20OMe modifications on
the 30-end and found that 4 20OMe nt led to increased
silencing efficiency after 48 h, whereas 6 20OMe strongly in-
hibited and 8–10 20OMe insertions completely abolished
gene silencing. This is consistent with previous reports
demonstrating the inhibition of fully or highly 20OMe-
modified siRNAs (22–24,27,32). For the first time (to our
knowledge), we were able to unravel the mechanism of
20OMe-mediated gene silencing inhibition on the 30-end.
By applying FCCS in living cells, we showed that neither
the affinity nor the asymmetry of guide-strand incorporation
was affected. By contrast, we demonstrated that removal of
the passenger strand, a step that is strictly required for
RISC activation and maturation, was strongly inhibited.
Furthermore, the inhibitory effect on passenger-strand
release occurred only when 20OMe nt were present on the
guide strand. Although we found that the cleavage activity
of RISC, which is needed for efficient passenger strandBiophysical Journal 100(12) 2981–2990removal after 3 h, was mainly affected, we also detected
passenger-strand release of up to 50% of bound siRNA after
12 h of siRNA supply. This indicates that a less-efficient
bypass mechanism exists without passenger-strand cleavage,
resulting in guide-strand-loaded RISC (activated RISC).
This demonstrates the advantage of the FCCS assay, which
allows RISC assembly to bemeasured at early and late stages
after siRNA supply. In addition, we showed that RISCs
loaded with cleavage-impaired 20OMe guide strands were
still capable of recognizing and binding their target RNA.
Surprisingly, they associated to higher extent with the target
RNA compared with a bulge-forming guide strand, which
should also inhibit target RNA cleavage. We can only spec-
ulate as to why they associate with higher amplitudes with
the target RNA, but most probably this reflects a stabilization
effect of the 20OMe modification on the RISC target interac-
tion or increased affinity of the RISC-target interaction
caused either by the increased affinity due to the complete
hybridization of the guide-target RNA duplex or by protec-
tion of the guide strand against nucleases.
Although Chiu and Rana (22) previously showed that
20OMe inhibits target-RNA cleavage in vitro, they could
not exclude the possibility that passenger-strand release
was also affected or sufficient.
Our results showing silencing inhibition with 20OMe-
modified nt from 6–10 from the 30end are in agreement
with the results of Wang et al. (13), who showed that
hAgo2-mediated cleavage occurs only with guide/target
RNA duplexes larger than 16 nt. Therefore, the 30-RNA
region from 15–21 of the guide strand seems to be important
for the transition into or stabilization of the active confirma-
tion, which can be inhibited by 20OMe-modified nt.
The insertion of 2 20OMe nt on the 50-end inhibited gene
silencing activity when it was present on the guide strand.
We showed that 3 h after siRNAwas supplied, in similarity
to the early stages of RISC assembly, neither the affinity nor
the asymmetry was affected. In contrast to the 30-end modi-
fication, the 50-end 20OMe nt did not interfere with strand
separation. Of interest, after 12 h we detected a strong
decrease in loaded RISC levels, indicating that the 2
20OMe nt on the 50-end somehow destabilized the RISC-
guide strand complex. We also showed that this 50-end
modification led to increased RISC-target RNA levels,
thereby reducing the level of target RNA cleavage effi-
ciency. We propose that 20OMe on the 50-end leads to
reduced hAgo2-guide strand stability in similarity to the
destabilization with a guide strand lacking the 50-phosphate
(33). This would also explain why passenger-strand removal
is unaffected, whereas target RNA cleavage seems to be less
efficient. Nevertheless, the effect of 20OMe nucleotides on
the 50-end may be sequence-dependent, as other groups
also found no inhibitory function of 1–2 20OMe-modified
nucleotides on the 50-end (20,26).
To our surprise, we could only detect marginal effects
with inserted 20OMe nt at the cleavage site at positions
Effects of 20-OMe Modified siRNAs 29899–11. In our standard dual luciferase assay, we detected
a reduction in silencing activity by <8% for the double-
and guide-modified duplexes. Nevertheless, our FCCS assay
was able to detect minor reductions in strand separation.
This is in agreement with a previous study by Leuschner
et al. (31), who showed passenger-strand cleavage inhibition
with 20OMe on position 9 of the passenger strand. The
minor inhibition detected may reflect the fact that we per-
formed our measurements in living cells with optimal
siRNA processing conditions and in the presence of an
RISC loading complex, whereas Leuschner et al. used puri-
fied minimal RISC, which represents the single hAgo2
protein alone. Nevertheless, we were able to detect slightly
higher levels of RISC-target RNA interaction, indicating
a slightly inhibited target RNA cleavage process.
This study shows that our intracellular FCCS assays are
very well suited for investigating the individual steps of
RISC assembly with very high specificity and sensitivity
in real time. We were able to show a direct correlation
between cleavage activity and target interaction, which
can also be used to determine the cleavage properties of
guide RNAs, thereby allowing for multiparameter measure-
ments. Our results also demonstrate that various positions of
20OMe nt affect RISC assembly and activity in different
ways. Therefore, 20OMe-modified 30-end siRNAs with up
to 8–10 nt can be used to mimic miRNA-like interactions
of RISC with its target RNA, increasing the stability of
the RISC-target-RNA complex. These results can lead to
the development of a new type of therapeutic small RNAs
because they allow one to apply miRNA-like duplexes
with increased affinities to their target RNA.SUPPORTING MATERIAL
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